{"id":"W2322121630","doi":"10.1056/nejm200103083441001","title":"Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis","year":2001,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":6149,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Royal University Hospital","funders":"","keywords":"Drotrecogin alfa; Medicine; Placebo; Sepsis; Internal medicine; Clinical endpoint; Adverse effect; Randomized controlled trial; Surgery; Septic shock; Severe sepsis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}